Update portfolioENPage “portfolioEN”

content/portfolioEN.md

@@ -97,22 +97,6 @@ portfolioEN:
       Meilishuo in 2016 to create a comprehensive fashion business with
       offerings that range from fashion content to e-commerce and technology. In
       December 2018, MOGU listed on the New York Stock Exchange."
-  - logo: /static/img/回响科技_logo.png
-    logo2: /static/img/回响科技_logo.png
-    sinceDate: 2021-08-16T13:38:36.983Z
-    nameEN: ECHO TECH
-    type: 新消费
-    website: https://qiandaoapp.com/
-    descriptionEN: Echo Tech is a network for all hobbies. We are committed to
-      solving the core needs of users and creating a platform integrating
-      services and features such as community, news, e-commerce and trading
-      platform. The company's biggest product, Chaowanzu(潮玩族), has millions of
-      users in just two years, with more than 100 million yuan GMV per month, an
-      increase of 10 times compared with 2020. It is the largest fashion toys
-      trading platform in China. It has successfully held CTS (Chaowanzu Toy
-      Show) offline, attracting more than 20000 users and more than 300 brands
-      and studios. By the end of 2021, we raised nearly US $100 million in
-      Series B funding.
   - logo: /static/img/食物主义-logo.png
     logo2: /static/img/食物主义-logo.png
     sinceDate: 2021-08-19T10:34:50.334Z
@@ -173,7 +157,7 @@ portfolioEN:
       innovative platform integrates the authentic content shared by its
       community with commerce, quickly becoming one of the most popular
       destinations for making lifestyle decisions.
-  - sinceDate: ""
+  - sinceDate: 2024-09-26T16:00:00.000Z
     nameEN: Dongchedi
     descriptionEN: Dongchedi is a one-stop automotive media and service platform for
       "viewing cars, choosing cars, and buying cars" under ByteDance. Its
@@ -234,6 +218,21 @@ portfolioEN:
       utilize proprietary synthetic biology technology to develop and
       manufacture multiple types of recombinant collagen and rare ginsenosides
       in-house.
+  - logo: /static/img/bulukelogo.png
+    logo2: /static/img/bulukelogo.png
+    sinceDate: 2020-12-03T11:22:46.597Z
+    nameEN: Bloks Technology Group
+    type: 新消费
+    website: https://www.bloks.com/
+    descriptionEN: 'Shanghai Bloks Technology Group adheres to the mission of
+      "Technology Accompanying Growth" and is committed to using innovative
+      technology to create the ultimate product experience and create long-term
+      value for users. The group currently has four core business segments,
+      including: Block, Animation, Online Education and Preschool Education.
+      Bloks strives to build a full ecological industry chain with "building
+      blocks +" as the core, in the meanwhile, applies blocks to various
+      application scenarios and lays out a complete industry vision, including T
+      (Toy) + A (Animation) + G (Game)+E (Education).'
   - logo: /static/img/genkiforest.png
     logo2: /static/img/genkiforest-2x.png
     sinceDate: 2019-12-27T05:36:12.161Z
@@ -256,25 +255,10 @@ portfolioEN:
       travel demands. The mission of Hellobike is “technology promotes travel
       evolution”. The Company aims to provide a sustainable three-dimensional
       shared travel solution to help build smart cities.
-  - logo: /static/img/bulukelogo.png
-    logo2: /static/img/bulukelogo.png
-    sinceDate: 2020-12-03T11:22:46.597Z
-    nameEN: Bloks Technology Group
-    type: 新消费
-    website: https://www.bloks.com/
-    descriptionEN: 'Shanghai Bloks Technology Group adheres to the mission of
-      "Technology Accompanying Growth" and is committed to using innovative
-      technology to create the ultimate product experience and create long-term
-      value for users. The group currently has four core business segments,
-      including: Block, Animation, Online Education and Preschool Education.
-      Bloks strives to build a full ecological industry chain with "building
-      blocks +" as the core, in the meanwhile, applies blocks to various
-      application scenarios and lays out a complete industry vision, including T
-      (Toy) + A (Animation) + G (Game)+E (Education).'
   - logo: /static/img/bebebus_logo.png
     logo2: /static/img/bebebus_logo.png
     sinceDate: 2020-12-28T10:34:50.091Z
-    nameEN: bebebus
+    nameEN: BeBeBus
     type: 新消费
     website: http://www.bebebus.cn/
     descriptionEN: BEBEBOO IOT TECHNOLOGY(SHANGHAI)CO.,LTD. is a technology and
@@ -366,6 +350,17 @@ portfolioEN:
       focus on consumer electronics, innovation and creativity led Baseus to
       where it is right now with numerous patents, international design awards,
       and a vast variety of product.
+  - sinceDate: 2020-07-03T09:00:22.362Z
+    nameEN: Halara
+    descriptionEN: Halara is a Chinese direct-to-consumer women's apparel brand and
+      e-commerce platform, primarily known for its affordable and stylish
+      activewear. Founded in 2020 by Joyce Zhang, the company has gained
+      significant popularity through social media. Halara's products include
+      leggings, women's underwear, exercise dresses, and skorts.
+    website: https://thehalara.com/
+    type: 新消费
+    logo: /static/img/logo-3.png
+    logo2: /static/img/logo-3.png
   - logo: /static/img/kastking_logo_22.10.png
     logo2: /static/img/kastking_logo_22.10.png
     sinceDate: 2021-12-03T09:59:40.827Z
@@ -454,23 +449,30 @@ portfolioEN:
   - logo: /static/img/零食很忙_logo.png
     logo2: /static/img/零食很忙_logo.png
     sinceDate: 2021-05-10T13:40:46.917Z
-    nameEN: Lingshihenmang
+    nameEN: BUSY MING. Group
     type: 新消费
     website: http://www.hnlshm.com/
-    descriptionEN: Hunan Lingshihenmang Commercial Chain Co., Ltd. is a professional
-      snacks chain company. Adhering to the mission of “a people’s snack brand
-      with inexpensive and tasty snacks”, the Company has comprehensively
-      remained close up to the people’s lives and meeting more popular snack
-      needs. The Company has been innovating all the way, building its core
-      advantages in product selection, quality control, shop standardization,
-      brand development, supply chain development, and other aspects. Going
-      beyond the traditional, the Company has opened up a new snack sales model.
-      It has been growing at an industry-leading rate of establishing “two new
-      stores per day”, with the number of shops exceeding 1,000 by March 2022.
-      In just over four years, the Company has grown to the leading local snack
-      chain brand in Hunan province. In the future, the Company will continue to
-      uphold its mission to provide more professional and comprehensive snacking
-      solutions to an increasing number of people.
+    descriptionEN: '"Snack is Busy" was founded in 2017, while "Zhaoyiming Snack"
+      started in 2019. The two brands completed a merger in November 2023 and
+      were integrated into "BUSY MING. Group", which has greater scale and
+      network advantages. As of December 31, 2024, BUSY MING. Group had a total
+      of 14,394 stores. Its brands have become the preferred national affordable
+      snack brands for consumers. According to a report by Frost & Sullivan, in
+      terms of GMV in 2024, BUSY MING. Group is the largest chain retailer of
+      casual food and beverages in China and ranks as the fourth largest chain
+      retailer of food and beverages in the country.'
+  - sinceDate: 2019-01-28T09:00:22.231Z
+    nameEN: Himaxx
+    website: https://www.hpcang.com/index.html
+    type: 新消费
+    logo: /static/img/logo-15.png
+    logo2: /static/img/logo-15.png
+    descriptionEN: Himaxx is the pioneer in the warehouse-style discount retail
+      industry. Himaxx has established partnerships with over 2,000 renowned
+      global brands. Relying on their strong brand influence and user
+      penetration, Himaxx brings a stable foundation of foot traffic to offline
+      stores. Meanwhile, leveraging its economies of scale, Himaxx offers
+      consumers genuine products from big brands at extremely low discounts.
   - logo: /static/img/meituandianp-2x.png
     logo2: /static/img/meituandianp-2x.png
     sinceDate: 2016-08-12T00:00:00.000Z
@@ -579,6 +581,21 @@ portfolioEN:
       transportation, supply chain finance, logistics consulting, sharing
       platform, etc. Yuanfu Logitics is committed to be the top leader in
       promoting the development of growing logistics enterprises.
+  - sinceDate: 2024-04-18T09:00:21.983Z
+    nameEN: Moonshot AI
+    website: https://www.moonshot.cn/
+    descriptionEN: Moonshot AI was founded in March 2023 and is committed to finding
+      the optimal solution to convert energy into intelligence and creating a
+      versatile new productivity. It has launched Kimi, an intelligent assistant
+      product that supports deep thinking, multimodal reasoning, and can input
+      200,000-word long texts. Our founding team members have been involved in
+      the research & development of multiple Large Language Models, including
+      Google Gemini, Google Bard, Pangu NLP, and Wudao. Several of our core
+      technologies have been adopted by world-known products such as Google
+      PaLM, Meta LLaMa, and Stable Diffusion.
+    type: 新消费
+    logo: /static/img/logo-27.png
+    logo2: /static/img/logo-27.png
   - sinceDate: 2023-04-18T12:38:00.000Z
     nameEN: Yuaiweiwu
     descriptionEN: Yuaiweiwu is dedicated to promoting the deep integration of
@@ -604,6 +621,30 @@ portfolioEN:
     logo2: /static/img/miao_logo.png
     website: https://miao.company/
     type: 新消费
+  - sinceDate: 2023-07-28T09:00:22.469Z
+    nameEN: LiblibAI
+    website: https://www.liblib.art/
+    type: 新消费
+    descriptionEN: LiblibAI was founded in March 2023 and is an AI-native app
+      company developing multimodal generation tools. Focused on AI content
+      creation and sharing in professional scenarios, we provide creative
+      workers with professional, reliable, and efficient tools, leading the
+      paradigm shift in China's creative content production and consumption.
+    logo: /static/img/logo-4.png
+    logo2: /static/img/logo-4.png
+  - sinceDate: 2024-12-17T09:00:22.565Z
+    nameEN: IdeaFlow
+    descriptionEN: IdeaFlow, founded in 2023, focuses on creating a new generation
+      of content platforms driven by multimodal AI. The company's core product,
+      "Zaomengciyuan" is positioned to serve young users. By integrating
+      generative AI technology, it provides an interactive and plot-based
+      virtual character interaction experience. Through highly engaging
+      interactive content, Zaomengciyuan has gradually established a new content
+      consumption ecosystem, attracting a large number of users.
+    website: https://ciyuan.ideaflow.pro/
+    type: 新消费
+    logo: /static/img/logo-28.png
+    logo2: /static/img/logo-28.png
   - logo: /static/img/Huami.png
     logo2: /static/img/Huami@2x.png
     sinceDate: 2014-11-20T00:00:00.000Z
@@ -719,7 +760,7 @@ portfolioEN:
   - logo: /static/img/innovusion_logo.png
     logo2: /static/img/innovusion_logo.png
     sinceDate: 2016-11-22T13:47:29.359Z
-    nameEN: Innovusion
+    nameEN: Seyond
     type: 新科技
     website: https://www.innovusion.info/
     descriptionEN: Founded in 2016, Innovusion has core R&D teams in Silicon Valley,
@@ -733,6 +774,76 @@ portfolioEN:
       controllable costs, Innovusion is cooperating with numerous leading
       companies in the fields of smart transportation, rail transit and
       industrial automation.
+  - sinceDate: 2023-01-05T09:00:22.134Z
+    nameEN: Haitian Die Casting
+    descriptionEN: Haitian Die Casting is one of the industries of Haitian Group,
+      adhering to philosophy and management concept of Haitian Group, and
+      maintaining technical innovation and win-win cooperations to provide
+      customers with complete sets of high-pressure casting equipment and
+      complete solutions with superior cost performance. In the middle of 2021,
+      new die casting machine production base of Haitian Die Casting in Beilun,
+      Ningbo. After the base is fully put into use, it will have an annual
+      production capacity of 4000 die casting machines.
+    website: https://haitian-dc.com/
+    type: 新科技
+    logo: /static/img/logo-11.png
+    logo2: /static/img/logo-11.png
+  - logo: /static/img/zhongchu_logo_23-7.png
+    logo2: /static/img/zhongchu_logo_23-7.png
+    sinceDate: 2021-11-30T07:50:29.892Z
+    nameEN: ZHONG-CHU-GUO-NENG
+    type: 新科技
+    website: https://www.caes.store/
+    descriptionEN: ZHONG-CHU-GUO-NENG is a pioneer and leader in advanced
+      compressed-air energy storage systems. The company possesses the full
+      range of capabilities in R&D, design, core equipment manufacturing,
+      engineering implementation, as well as power plant investment and
+      operation for advanced compressed-air energy storage systems. The team has
+      successfully developed and implemented the world's first 1.5MW, 10MW, and
+      100MW advanced compressed-air energy storage demonstration systems.
+  - logo: /static/img/weview_logo_23-7.png
+    logo2: /static/img/weview_logo_23-7.png
+    sinceDate: 2022-05-26T07:50:31.077Z
+    nameEN: WeView
+    type: 新科技
+    website: https://www.weview.com/
+    descriptionEN: WeView is a high-tech intelligent manufacturing enterprise,
+      committed to the research and development, innovative application and
+      industrial promotion of new energy storage technology. We have gathered a
+      group of scientists and experts worldwide. WeView actively responds to the
+      challenges of global energy system transformation in order to create an
+      everlasting future for humankind and nature.
+  - sinceDate: 2023-10-09T12:46:00.000Z
+    nameEN: Linden Chassistech
+    descriptionEN: Linden Chassistech, founded in July 2023, specializes in the
+      research, production, matching, and tuning of automotive electronic
+      control shock absorbers. The company aims to meet the demand for chassis
+      upgrades in new energy vehicles, accelerating the transition of electric
+      vehicle chassis into the era of intelligence and personalization.
+    logo: /static/img/logo-18.png
+    logo2: /static/img/logo-18.png
+    type: 新科技
+  - sinceDate: 2024-01-22T12:47:00.000Z
+    nameEN: BMSER Technology
+    descriptionEN: Founded in 2012, BMSER Technology is committed to becoming a
+      world-class new energy industry solution provider. Focusing on BMS, it
+      provides high-security, high-reliability, high-performance products and
+      high-quality services for applications such as smart energy storage,
+      power, communication base station backup power supply, and echelon
+      utilization.
+    website: https://www.bmser.com/
+    type: 新科技
+    logo: /static/img/xieneng_logo.png
+    logo2: /static/img/xieneng_logo.png
+  - sinceDate: 2023-11-29T12:45:00.000Z
+    nameEN: Zhongkeqingyi
+    descriptionEN: Zhongkeqingyi, established in May 2022, was initiated by a team
+      with a background in the Chinese Academy of Sciences. The company focuses
+      on the research, production, and sales of innovative membrane materials
+      for new energy and high-value-added applications.
+    logo: /static/img/zhongkeqingyi_logo.png
+    logo2: /static/img/zhongkeqingyi_logo.png
+    type: 新科技
   - logo: /static/img/Seeyon.png
     logo2: /static/img/Seeyon@2x.png
     sinceDate: 2017-02-15T00:00:00.000Z
@@ -767,57 +878,6 @@ portfolioEN:
       sizes and industries, making Baijiayun Group a one-stop video technology
       solution provider. Baijiayun Group trades on the Nasdaq Capital Market
       with the ticker symbol RTC.
-  - logo: /static/img/lingdilogo.png
-    logo2: /static/img/lingdilogo.png
-    sinceDate: 2019-10-31T12:17:22.939Z
-    nameEN: Style3D
-    type: 新科技
-    website: http://www.linctex.com
-    descriptionEN: Founded in November 2015, Linctex is committed to reconstructing
-      the fashion industry with 3D digitalization. Style3D of Linctex is the
-      world's leading 3D platform for fashion supply chain, starting from the
-      R&D and design link that most restricts the efficiency of the apparel
-      industry, providing apparel companies with the whole chain of digital
-      services from 3D design, pushing and reviewing models, 3D alteration to
-      direct link production and online exhibition. Our core products are
-      Style3D Studio digital modeling and design software, Style3D Fabric
-      digital fabric processing software, Style3D Cloud R&D whole process
-      collaboration platform, Sukuan3D model creation supply chain platform,
-      cooperation with clients such as Bosideng, Septwolves, Lilanz, Purcotton,
-      Ellassay, Wensli, Broadcast, Aimer, etc. We have also reached 3D digital
-      cooperation with Tmall, Alibaba International Station and other e-commerce
-      platforms for apparel.
-  - logo: /static/img/dianxiaomi_logo_22.10.png
-    logo2: /static/img/dianxiaomi_logo_22.10.png
-    sinceDate: 2021-02-02T10:03:42.840Z
-    nameEN: Dianxiaomi
-    type: 新科技
-    website: https://www.dianxiaomi.com
-    descriptionEN: Founded in 2014, Dianxiaomi is a global leading e-commerce IT
-      service company based in Shenzhen. It is focused on providing SaaS systems
-      to global online sellers, making “Global Buying and Selling”easier. Its
-      products include “Dianxiaomi ERP”, “Sellfox”, “BigSeller”, “UpSeller,
-      Duoke”, “17TRACK”, “UpDeals”, “Xiao Mi Yuncang”, etc. Dianxiaomi covers
-      the key links needed in the e-commerce industry chain, and enabling
-      sellers to reduce costs and increase efficiency in an all-round way.
-      Dianxiaomi has served more than 1.5 million global merchants, and has
-      achieved in-depth cooperation with 50+ top e-commerce platforms, 1,600+
-      high-quality logistics  providers, and 80+ overseas warehouses in the
-      world.
-  - logo: /static/img/zixun_logo_23-7.png
-    logo2: /static/img/zixun_logo_23-7.png
-    sinceDate: 2021-06-22T07:50:25.900Z
-    nameEN: Zixun
-    type: 新科技
-    website: https://www.fzzixun.com/
-    descriptionEN: Zixun engages in the research and development of cross-border
-      e-commerce digital asset security management platforms. With the Ziniao
-      browser as the core, it closely follows the needs of cross-border
-      e-commerce users. The core technologies of big data, cloud computing, and
-      artificial intelligence have expanded into a series of products, to build
-      a cross-border e-commerce service ecosystem, and provide global sellers
-      with more in-depth digital asset security custody services and data
-      operation guidance to help Chinese manufacturing go overseas.
   - logo: /static/img/xtransfer_logo.png
     logo2: /static/img/xtransfer_logo.png
     sinceDate: 2017-07-13T10:04:48.682Z
@@ -833,79 +893,20 @@ portfolioEN:
       United States, Canada, Japan, Australia and Singapore. To date, XTransfer
       has obtained local payment licenses in Hong Kong, the United Kingdom, the
       United States, Canada, and Australia.
-  - logo: /static/img/腾银财智-logo-2x.png
-    logo2: /static/img/腾银财智-logo-2x.png
-    sinceDate: 2020-02-21T13:52:27.970Z
-    nameEN: Tenwit
-    type: 新科技
-    website: https://www.tenwit.com/
-    descriptionEN: Tenwit is a fintech company strategically invested by Tencent
-      founded in 2018. Providing end-to-end full-stack customers operation
-      solutions and new paradigm of digitalization in the WeChat ecosystem,
-      Tengyin committed to becoming the digital infrastructure for retail
-      banking. With the support of Tencent Fintech,Tenwit now achieves
-      cooperation with numbers of state-owned banks and over 60% of large
-      stock-holding banks, more than 150 finance institutions at home and aboard
-      served by us and helping them to offer exclusive financial service for
-      more than 100 millions of WeChat users. And Tenwit has become a leading
-      enterprise in private traffic operations and digital operations  of the
-      financial industry.
-  - logo: /static/img/weview_logo_23-7.png
-    logo2: /static/img/weview_logo_23-7.png
-    sinceDate: 2022-05-26T07:50:31.077Z
-    nameEN: WeView
-    type: 新科技
-    website: https://www.weview.com/
-    descriptionEN: WeView is a high-tech intelligent manufacturing enterprise,
-      committed to the research and development, innovative application and
-      industrial promotion of new energy storage technology. We have gathered a
-      group of scientists and experts worldwide. WeView actively responds to the
-      challenges of global energy system transformation in order to create an
-      everlasting future for humankind and nature.
-  - logo: /static/img/zhongchu_logo_23-7.png
-    logo2: /static/img/zhongchu_logo_23-7.png
-    sinceDate: 2021-11-30T07:50:29.892Z
-    nameEN: ZHONG-CHU-GUO-NENG
-    type: 新科技
-    website: https://www.caes.store/
-    descriptionEN: ZHONG-CHU-GUO-NENG is a pioneer and leader in advanced
-      compressed-air energy storage systems. The company possesses the full
-      range of capabilities in R&D, design, core equipment manufacturing,
-      engineering implementation, as well as power plant investment and
-      operation for advanced compressed-air energy storage systems. The team has
-      successfully developed and implemented the world's first 1.5MW, 10MW, and
-      100MW advanced compressed-air energy storage demonstration systems.
-  - sinceDate: 2023-11-29T12:45:00.000Z
-    nameEN: Zhongkeqingyi
-    descriptionEN: Zhongkeqingyi, established in May 2022, was initiated by a team
-      with a background in the Chinese Academy of Sciences. The company focuses
-      on the research, production, and sales of innovative membrane materials
-      for new energy and high-value-added applications.
-    logo: /static/img/zhongkeqingyi_logo.png
-    logo2: /static/img/zhongkeqingyi_logo.png
-    type: 新科技
-  - sinceDate: 2023-10-09T12:46:00.000Z
-    nameEN: Linden Chassistech
-    descriptionEN: Linden Chassistech, founded in July 2023, specializes in the
-      research, production, matching, and tuning of automotive electronic
-      control shock absorbers. The company aims to meet the demand for chassis
-      upgrades in new energy vehicles, accelerating the transition of electric
-      vehicle chassis into the era of intelligence and personalization.
-    logo: /static/img/linde-chassistech_logo.png
-    logo2: /static/img/linde-chassistech_logo.png
-    type: 新科技
-  - sinceDate: 2024-01-22T12:47:00.000Z
-    nameEN: BMSER Technology
-    descriptionEN: Founded in 2012, BMSER Technology is committed to becoming a
-      world-class new energy industry solution provider. Focusing on BMS, it
-      provides high-security, high-reliability, high-performance products and
-      high-quality services for applications such as smart energy storage,
-      power, communication base station backup power supply, and echelon
-      utilization.
-    website: https://www.bmser.com/
+  - logo: /static/img/zixun_logo_23-7.png
+    logo2: /static/img/zixun_logo_23-7.png
+    sinceDate: 2021-06-22T07:50:25.900Z
+    nameEN: Zixun
     type: 新科技
-    logo: /static/img/xieneng_logo.png
-    logo2: /static/img/xieneng_logo.png
+    website: https://www.fzzixun.com/
+    descriptionEN: Zixun engages in the research and development of cross-border
+      e-commerce digital asset security management platforms. With the Ziniao
+      browser as the core, it closely follows the needs of cross-border
+      e-commerce users. The core technologies of big data, cloud computing, and
+      artificial intelligence have expanded into a series of products, to build
+      a cross-border e-commerce service ecosystem, and provide global sellers
+      with more in-depth digital asset security custody services and data
+      operation guidance to help Chinese manufacturing go overseas.
   - logo: /static/img/shuidilogo.jpg
     logo2: /static/img/shuidilogo.jpg
     sinceDate: 2016-07-19T00:00:00.000Z
@@ -1004,6 +1005,22 @@ portfolioEN:
       service network covers the whole country and we will continue to work
       closely with national partners to give full play to its advantages in
       various fields to implement convenient localized services.
+  - logo: /static/img/pufanglogo.png
+    logo2: /static/img/pufanglogo.png
+    sinceDate: 2020-08-27T12:45:54.445Z
+    nameEN: ProfuondBio
+    type: 医疗健康
+    website: http://www.profoundbiosz.cn/
+    descriptionEN: ProfuondBio is aiming to help patients with cancer through the
+      discovery and development of novel targeted therapeutics with curative
+      potential. We are focused on discovering and advancing novel classes of
+      therapeutics that are designed to leverage the immune system to eradicate
+      cancer. For patients whose immune systems are insufficient to mount an
+      anti-cancer response, we also develop therapeutics that delivery a small
+      molecule payload specifically to tumor cells. Our team of experienced
+      scientists take a fresh look at how to best eradicate cancer by taking an
+      open, creativity approach to drug discovery and then leverage our broad
+      experience in drug development to take an efficient path to patients.
   - sinceDate: 2023-11-18T12:48:00.000Z
     nameEN: Alto Neuroscience
     descriptionEN: Alto Neuroscience is a clinical-stage biopharmaceutical company
@@ -1019,28 +1036,24 @@ portfolioEN:
     logo2: /static/img/alto_logo.png
     website: https://www.altoneuroscience.com/
     type: 医疗健康
-  - logo: /static/img/weizhijunlogo.png
-    logo2: /static/img/weizhijunlogo.png
-    sinceDate: 2018-11-27T08:21:33.948Z
-    nameEN: Xbiome
+  - logo: /static/img/yinminglogo.png
+    logo2: /static/img/yinminglogo.png
+    sinceDate: 2021-03-05T12:44:55.916Z
+    nameEN: MingMed Biotech
     type: 医疗健康
-    website: http://xbiome.com/
-    descriptionEN: Shenzhen Xbiome Co. Ltd., established in 2017, is China's first
-      AI-driven microbiome drug development company, dedicated to making the
-      utmost of clinical data and AI technology to break the R&D bottleneck and
-      develop microbiome drugs for currently unmet medical needs. Xbiome creates
-      an innovative, discovery platform that combines industry-leading AI
-      technology with advanced bioengineering practices that dramatically speed
-      up the drug development cycle and increase the success rate of drug
-      candidates. Based on intestinal flora of patients with different
-      indications, rationally designed microbiome drugs are provided for
-      treatment. Aiming to achieve the prevention and management of chronic
-      diseases and subhealth, Xbiome leads the pharmaceutical industry into a
-      new era. Xbiome is led by a team of scientists from MIT, Harvard,
-      Stanford, Johns Hopkins University, Tsinghua University, Peking
-      University, etc., and the R&D team consists of veterans from world-class
-      pharmaceuticals and biotech companies including Pfizer and Bristol-Myers
-      Squib.
+    website: http://www.ming-med.com/
+    descriptionEN: MingMed Biotech is a clinical stage platform company dedicated to
+      developing First-in-Class pharmaceutical products. Our R & D team is
+      formed by globally top-notch scientists and specialists, while our
+      scientific committee consists of influential scientists in the world. We
+      have already made world-class breakthroughs in developing novel therapies
+      in the fields of ophthalmology, immune-oncology, gene editing-based
+      immunotherapy, medical aesthetics and pet medicine. There are currently
+      over 10 products in our R&D pipeline, most of which are First-in-Class
+      medications for unmet medical needs and already in either clinical or
+      preclinical stages. MindMed is committed to develop innovative medicines
+      targeting the true causes of diseases. With this mission, MindMed strives
+      to be a leading biopharma company in the world.
   - logo: /static/img/sironax_logo_22.10.png
     logo2: /static/img/sironax_logo_22.10.png
     sinceDate: 2022-07-22T10:13:43.169Z
@@ -1089,24 +1102,6 @@ portfolioEN:
       dozen of drug candidates, of which the core product of a non-cholic acid
       drug molecule CS0159 targeting FXR will be scheduled to simultaneously
       apply for clinical trial registration to the FDA and NMPA in July 2021.
-  - logo: /static/img/yinminglogo.png
-    logo2: /static/img/yinminglogo.png
-    sinceDate: 2021-03-05T12:44:55.916Z
-    nameEN: MingMed Biotech
-    type: 医疗健康
-    website: http://www.ming-med.com/
-    descriptionEN: MingMed Biotech is a clinical stage platform company dedicated to
-      developing First-in-Class pharmaceutical products. Our R & D team is
-      formed by globally top-notch scientists and specialists, while our
-      scientific committee consists of influential scientists in the world. We
-      have already made world-class breakthroughs in developing novel therapies
-      in the fields of ophthalmology, immune-oncology, gene editing-based
-      immunotherapy, medical aesthetics and pet medicine. There are currently
-      over 10 products in our R&D pipeline, most of which are First-in-Class
-      medications for unmet medical needs and already in either clinical or
-      preclinical stages. MindMed is committed to develop innovative medicines
-      targeting the true causes of diseases. With this mission, MindMed strives
-      to be a leading biopharma company in the world.
   - logo: /static/img/kelan__logo_23-7.png
     logo2: /static/img/kelan__logo_23-7.png
     sinceDate: 2022-12-08T07:50:27.406Z
@@ -1117,49 +1112,59 @@ portfolioEN:
       innovative target identification and first-in-class drug discovery in the
       field of cholesterol-related diseases, such as hyperlipidemia, obesity,
       atherosclerosis, and nonalcoholic steatohepatitis.
-  - logo: /static/img/pufanglogo.png
-    logo2: /static/img/pufanglogo.png
-    sinceDate: 2020-08-27T12:45:54.445Z
-    nameEN: ProfuondBio
+  - logo: /static/img/weizhijunlogo.png
+    logo2: /static/img/weizhijunlogo.png
+    sinceDate: 2018-11-27T08:21:33.948Z
+    nameEN: Xbiome
     type: 医疗健康
-    website: http://www.profoundbiosz.cn/
-    descriptionEN: ProfuondBio is aiming to help patients with cancer through the
-      discovery and development of novel targeted therapeutics with curative
-      potential. We are focused on discovering and advancing novel classes of
-      therapeutics that are designed to leverage the immune system to eradicate
-      cancer. For patients whose immune systems are insufficient to mount an
-      anti-cancer response, we also develop therapeutics that delivery a small
-      molecule payload specifically to tumor cells. Our team of experienced
-      scientists take a fresh look at how to best eradicate cancer by taking an
-      open, creativity approach to drug discovery and then leverage our broad
-      experience in drug development to take an efficient path to patients.
-  - logo: /static/img/xihuyungulogo.png
-    logo2: /static/img/xihuyungulogo.png
-    sinceDate: 2021-04-14T12:46:59.073Z
-    nameEN: Aldit
+    website: http://xbiome.com/
+    descriptionEN: Shenzhen Xbiome Co. Ltd., established in 2017, is China's first
+      AI-driven microbiome drug development company, dedicated to making the
+      utmost of clinical data and AI technology to break the R&D bottleneck and
+      develop microbiome drugs for currently unmet medical needs. Xbiome creates
+      an innovative, discovery platform that combines industry-leading AI
+      technology with advanced bioengineering practices that dramatically speed
+      up the drug development cycle and increase the success rate of drug
+      candidates. Based on intestinal flora of patients with different
+      indications, rationally designed microbiome drugs are provided for
+      treatment. Aiming to achieve the prevention and management of chronic
+      diseases and subhealth, Xbiome leads the pharmaceutical industry into a
+      new era. Xbiome is led by a team of scientists from MIT, Harvard,
+      Stanford, Johns Hopkins University, Tsinghua University, Peking
+      University, etc., and the R&D team consists of veterans from world-class
+      pharmaceuticals and biotech companies including Pfizer and Bristol-Myers
+      Squib.
+  - logo: /static/img/安道药业-logo-2x.png
+    logo2: /static/img/安道药业-logo-2x.png
+    sinceDate: 2021-12-20T13:53:45.773Z
+    nameEN: Kind Pharmaceuticals LLC
     type: 医疗健康
-    website: https://www.westlakegenetech.com
-    descriptionEN: Aldit is a biotech and biopharma startup, which is committed to
-      leverage AI technology to assist the discovery and development of novel
-      gene editing therapies. AIdit focuses on developing the cutting-edge
-      technologies based on the cooperation between the 3-high (high throughput,
-      high precision, high dimension) biotechnological data production and the
-      deep learning modeling. The AIdit team is highly multi-disciplined and has
-      gathered a group of young experts in the fields including molecular
-      biology, immunology, deep leaning and mathematics.
-  - logo: /static/img/shuimulogo.png
-    logo2: /static/img/shuimulogo.png
-    sinceDate: 2020-04-07T12:47:57.590Z
-    nameEN: Tomo BioSciences
+    website: http://www.kindpharmaceuticals.com/index.php
+    descriptionEN: Kind Pharmaceuticals LLC is a multinational pharmaceutical
+      company with a US site located at the Pharmaceutical Research Center in
+      San Francisco, and a China site founded in the Community of Industries in
+      Zhejiang Province in 2014. Kind was established by a group of seasoned
+      scientists with complementary global industry experience, focusing on new
+      drug R&D to improve lives over the world. Kind strives to form a new drug
+      development pattern focusing on small molecule targeted drugs and
+      biomacromolecule drugs to treat anemia, cancers, and hard-to-treat
+      diseases.
+  - sinceDate: 2023-12-12T09:00:22.671Z
+    nameEN: Allink
+    website: http://www.allinkbio.com/
     type: 医疗健康
-    website: https://www.shuimubio.com/
-    descriptionEN: Tomo BioSciences Ltd. (TomoBio) is a Cryo-EM and AI driven drug
-      discovery platform. Founded in 2017 at Tsinghua University with a core
-      team of outstanding life and computational scientists, AI and
-      pharmaceutical industry experts, TomoBio has successfully provided
-      structural biology and drug discovery services to more than 50 innovative
-      pharmaceutical companies and top research institutions from China, the
-      United States and Europe since its inception.
+    descriptionEN: Shanghai Allink Biotherapeutics Co., Ltd.established in 2023, is
+      a pioneering biotechnology company specializing in bispecific antibody and
+      antibody-drug conjugates (ADCs). The company's experienced R&D focuses on
+      the discovery and clinical development of a diverse of FIC/BIC
+      therapeutics. Powered by a proprietary bispecific antibody platform and
+      novel conjugation technology, Allink Biotherapeutics develops
+      next-generation BsADCs characterized by optimized drug-to-antibody ratios
+      (DARs), enhanced hydrophilicity, and superior stability. The company's
+      independent intellectual property portfolio underpins its technological
+      advantages in the field.
+    logo: /static/img/logo-7.png
+    logo2: /static/img/logo-7.png
   - logo: /static/img/doublerainbowlogo.png
     logo2: /static/img/doublerainbowlogo.png
     sinceDate: 2020-10-20T12:48:49.491Z
@@ -1177,21 +1182,85 @@ portfolioEN:
       wisdom distilled into the world’s traditional herbal medicines and a deep
       knowledgebase of modern disease biology, we develop nature-inspired new
       medicines for treating human diseases.
-  - logo: /static/img/安道药业-logo-2x.png
-    logo2: /static/img/安道药业-logo-2x.png
-    sinceDate: 2021-12-20T13:53:45.773Z
-    nameEN: Kind Pharmaceuticals LLC
+  - sinceDate: 2022-08-02T09:00:22.763Z
+    nameEN: Bivision
+    website: https://www.bivisionpharma.com/
     type: 医疗健康
-    website: http://www.kindpharmaceuticals.com/index.php
-    descriptionEN: Kind Pharmaceuticals LLC is a multinational pharmaceutical
-      company with a US site located at the Pharmaceutical Research Center in
-      San Francisco, and a China site founded in the Community of Industries in
-      Zhejiang Province in 2014. Kind was established by a group of seasoned
-      scientists with complementary global industry experience, focusing on new
-      drug R&D to improve lives over the world. Kind strives to form a new drug
-      development pattern focusing on small molecule targeted drugs and
-      biomacromolecule drugs to treat anemia, cancers, and hard-to-treat
-      diseases.
+    logo: /static/img/logo-17.png
+    logo2: /static/img/logo-17.png
+    descriptionEN: Bivision Pharmaceuticals, Inc., a clinical-stage
+      biopharmaceutical company, focuses on the discovery, development, and
+      commercialization of novel targeted radiopharmaceuticals to address
+      significant unmet medical needs. Bivision has a diversified R&D pipeline
+      cross different stage of drug discovery and development process. Its lead
+      drug candidate JH02, a Lutetium-177 labeled small molecule ligand
+      targeting Prostate Specific Membrane Antigen (PSMA) for the treatment of
+      patients with metastatic castration resistant prostate cancer (mCRPC) has
+      been approved by both FDA and CDE and currently is under Phase I/II
+      clinical trial. Since inception, Bivision has built a proprietary
+      technology platform which enables its drug R&D programs to be advanced to
+      clinical stage much fast. Bivision will strive to become a
+      patient-oriented biotech company committed to provide patients with better
+      radiopharmaceuticals which allow more patients to have a better quality of
+      life.
+  - sinceDate: 2021-05-24T11:00:55.273Z
+    nameEN: Haichang Biotech
+    website: http://www.zhejianghaichang.com/
+    type: 医疗健康
+    descriptionEN: Zhejiang Haichang Biotech Co., Ltd., Haichang Biotech is a global
+      trailblazer committed to pushing the boundaries of biomedical technologies
+      to better human health. With a strong emphasis on independent innovation
+      and a solid global intellectual property right foundation, we drive the
+      discovery and development of cutting-edge drug delivery systems. Our
+      expertise lies in nucleic acid technologies. We actively contribute to the
+      evolution of mRNA vaccine, small nucleic acid drugs, and complex
+      injections. Our broad product pipelines span various fields, encompassing
+      infectious disease prevention, tumor immunotherapy, antitumor therapy,
+      analgesia and more.
+    logo: /static/img/logo-10.png
+    logo2: /static/img/logo-10.png
+  - sinceDate: 2024-03-29T11:00:55.479Z
+    nameEN: Arnatar
+    website: https://www.arnatar.com/
+    descriptionEN: At Arnatar, we use various cutting edge RNA targeting antisense
+      technologies to develop novel therapies that modulate the origin of the
+      diseases, by reducing or increasing the expression of specific genes that
+      cause or contribute to disease. We are a group of dedicated and
+      experienced scientists with diverse expertise, including drug development,
+      RNA biology and chemistry, and with strong track records in bringing novel
+      molecules to the clinics as best-in-class or first-in-class novel RNA
+      therapies.
+    type: 医疗健康
+    logo: /static/img/新增-arnatar.png
+    logo2: /static/img/新增-arnatar.png
+  - sinceDate: 2023-08-09T11:00:55.770Z
+    nameEN: DotBio
+    website: https://www.dotbio.com/
+    descriptionEN: DotBio’s proprietary DotBody technology platform is based on the
+      concept of modular design. By prefabricating antibody modules with
+      specific functions, DotBio is able to combine them on demand to build
+      multi-functional antibodies. This high throughput process allows DotBio to
+      generate bi- and tri-specific antibodies, antibody-drug conjugates (ADCs)
+      and intracellular antibodies in a matter of months.
+    logo: /static/img/logo-2.png
+    logo2: /static/img/logo-2.png
+    type: 医疗健康
+  - sinceDate: 2022-10-20T11:00:56.180Z
+    nameEN: BridGene
+    website: https://www.bridgenebio.com/
+    descriptionEN: BridGene Biosciences is a biotechnology company focusing on
+      discovering and developing innovative small molecules that drug high value
+      yet previously undruggable targets, providing new paths to treat diseases.
+      Currently, about 90% of proteins associated with diseases cannot be
+      targeted by traditional therapies due to the lack of a known addressable
+      binding site. BridGene intends to change this by using its proprietary
+      Chemoproteomics platform, IMTAC™ (Isobaric Mass Tagged Affinity
+      Characterization). IMTAC™ enables the screening of small molecules against
+      all the proteins in live cells to discover drug candidates for high value
+      and hard-to-drug targets that cause diseases.
+    type: 医疗健康
+    logo: /static/img/logo-32.png
+    logo2: /static/img/logo-32.png
   - logo: /static/img/baiying_logo_22.10.png
     logo2: /static/img/baiying_logo_22.10.png
     sinceDate: 2022-08-26T10:07:55.240Z
@@ -1207,6 +1276,79 @@ portfolioEN:
       maturation, VHH library generation, and stable cell line development.
       Biointron has served thousands of biopharma/biotech companies working on
       antibody drugs, IVD, vaccines, cell therapies, etc.
+  - sinceDate: 2022-06-23T11:00:56.463Z
+    nameEN: Intellective Bio
+    website: https://www.intellectivebio.com.cn/
+    descriptionEN: Intellective Bio is a biopharmaceutical CDMO committed to
+      accelerating your product development and commercialization. We
+      efficiently use our modern infrastructure and cross-functional experts for
+      R&D to large-scale production volumes from 1 to 210000 liters. Our
+      multiple cGMP manufacturing plants, based in the biotech hub of Suzhou,
+      China are optimized for commercialization in ICH-regulated markets
+      including US, Europe, and China as well as other global territories. With
+      our track record in development and manufacturing of antibodies, ADCs,
+      fusion proteins, and other recombinant proteins, Intellective Bio is your
+      trusted one-stop CDMO partner.
+    type: 医疗健康
+    logo: /static/img/logo-31.png
+    logo2: /static/img/logo-31.png
+  - logo: /static/img/shuimulogo_new.png
+    logo2: /static/img/shuimulogo_new.png
+    sinceDate: 2020-04-07T12:47:57.590Z
+    nameEN: Shuimu Biosciences
+    type: 医疗健康
+    website: https://www.shuimubio.com/
+    descriptionEN: Shuimu Biosciences is a Cryo-EM and AI driven drug discovery
+      platform. Founded in 2017 at Tsinghua University with a core team of
+      outstanding life and computational scientists, AI and pharmaceutical
+      industry experts, TomoBio has successfully provided structural biology and
+      drug discovery services to more than 50 innovative pharmaceutical
+      companies and top research institutions from China, the United States and
+      Europe since its inception.
+  - logo: /static/img/xihuoumilogo.png
+    logo2: /static/img/xihuoumilogo.png
+    sinceDate: 2021-02-25T12:52:22.407Z
+    nameEN: Westlake Omics
+    type: 医疗健康
+    website: https://www.westlakeomics.com/index/index/index/lang/cn
+    descriptionEN: Founded in July 2020, Westlake Omics (wOmics) is a company
+      focused on using mass spectrometry and other high-throughput molecular
+      quantitative technologies to generate omics data , and applying AI
+      technology to analyze biomedical big data. The company is dedicated to
+      developing advanced mass spectrometry-based proteomics techniques for
+      minute amount of clinical specimens. wOmics's persistent efforts have been
+      propped by its breakthroughs in auxiliary clinical diagnostics and drug
+      discovery empowered by AI and omics big data, facilitating precision
+      medicine.
+  - sinceDate: 2022-01-31T11:00:56.837Z
+    nameEN: Helixon
+    descriptionEN: Earendil Labs is a biotech company redefining biopharmaceutical
+      innovation with its cutting-edge AI-powered platform. By combining
+      advanced machine learning, generative protein engineering, and
+      high-throughput experimental techniques, Earendil Labs and its affiliate
+      Helixon Therapeutics streamline drug discovery & research process with aim
+      of significantly accelerating drug development. Earendil Labs' proprietary
+      integrated framework enables precise optimization of functionality,
+      manufacturability, and developability of protein-based biologics with
+      first-in-class or best-in-class potential.
+    website: https://www.huashen.bio/
+    type: 医疗健康
+    logo: /static/img/logo-13.png
+    logo2: /static/img/logo-13.png
+  - sinceDate: 2022-07-28T11:00:57.404Z
+    nameEN: BioGeometry
+    descriptionEN: BioGeometry is a digital biology pioneer that specializes in
+      applying generative AI to protein design. Our AI-driven biologics design
+      platform (GeoBiologics) and high-throughput wet-lab validation platform
+      form a design-build-test-learn closed loop, empowering precise and
+      efficient protein design and optimization for biomedicine and synthetic
+      biology. BioGeometry was founded in 2022 by Prof. Jian Tang, a renowned
+      scientist in AI4Drug and deep learning on graphs, with Turing Award
+      laureate Yoshua Bengio serving as the chief scientific advisor.
+    website: https://www.biogeom.com/zh/
+    type: 医疗健康
+    logo: /static/img/baiaologo.png
+    logo2: /static/img/baiaologo.png
   - logo: /static/img/康诺思腾logo新.png
     logo2: /static/img/康诺思腾logo新.png
     sinceDate: 2019-12-05T13:56:52.977Z
@@ -1246,6 +1388,20 @@ portfolioEN:
       projects, such as National Key Research and Development Program, National
       Science and Technology Support Program and Beijing Municipal Science and
       Technology Program.
+  - sinceDate: 2021-03-22T11:00:57.862Z
+    nameEN: TrueHealth
+    website: https://www.truehealth.cn/
+    descriptionEN: TureHealth is a cutting-edge enterprise that takes artificial
+      intelligence and robotic control as its core technologies, and focuses on
+      the research and development and industrialization of intelligent robots
+      for soft tissue puncture diagnosis and treatment as well as organ repair.
+      Through the close integration of industry, academia, research institutions
+      and medical institutions, it integrates intelligent robotic systems into
+      the diagnosis and treatment processes, and serves as a driving force in
+      achieving the goal of Healthy China.
+    type: 医疗健康
+    logo: /static/img/logo-29.png
+    logo2: /static/img/logo-29.png
   - logo: /static/img/pamu__logo_23-7.png
     logo2: /static/img/pamu__logo_23-7.png
     sinceDate: 2021-08-03T07:50:28.636Z
@@ -1259,23 +1415,19 @@ portfolioEN:
       research and development efforts alongside physicians at the operating
       table with the goal to market our innovative therapeutic solutions and
       benefit patients around the world.
-  - logo: /static/img/mirxes.png
-    logo2: /static/img/mirxes-2x.png
-    sinceDate: 2018-10-31T04:21:23.894Z
-    nameEN: MiRXES
+  - sinceDate: 2023-09-22T11:00:58.217Z
+    nameEN: We-Linking
+    descriptionEN: We-Linking specializes in the design of clinical solutions,
+      engineering implementation, and clinical practice of medical-grade fully
+      implantable brain-computer interface (FiBCI) systems. Moving forward,
+      We-Linking is dedicated to researching the FiBCI system and is committed
+      to providing intelligent motor function replacement and repair medical
+      solutions for patients suffering from motor disabilities due to spinal
+      cord injuries and progressive freezing disease.
+    website: https://www.we-linking.com/
     type: 医疗健康
-    website: https://mirxes.com/
-    descriptionEN: Founded in 2014 as a spin-off from Singapore’s Agency for
-      Science, Technology, and Research (A*STAR) and National University of
-      Singapore (NUS), MiRXES is the world’s leading developer of microRNA
-      centric molecular diagnostic tests, with strong pipelines in Cancer,
-      Cardiovascular and Infectious diseases. MiRXES has physical presence in
-      Singapore, USA, China, and Japan with sales in over 40 countries globally.
-      In 2019, MiRXES launched GASTROClear, the world’s first microRNA blood
-      test for early detection of gastric cancer. In response to the COVID-19
-      pandemic, MiRXES worked with Singapore government agencies to launch
-      Fortitude Kit, Singapore’s first authorized COVID-19 RT-PCR test. Since
-      February 2020, millions of Fortitude tests have been deployed globally.
+    logo: /static/img/logo-21.png
+    logo2: /static/img/logo-21.png
   - logo: /static/img/qitanlogo.png
     logo2: /static/img/qitanlogo.png
     sinceDate: 2020-05-08T12:51:31.964Z
@@ -1294,19 +1446,65 @@ portfolioEN:
       sequence single molecules without PCR. Not only is its read-length longer,
       it is also faster, smaller in size, easier to use in a wider range of
       applications, and at a lower price.
-  - logo: /static/img/xihuoumilogo.png
-    logo2: /static/img/xihuoumilogo.png
-    sinceDate: 2021-02-25T12:52:22.407Z
-    nameEN: Westlake Omics
+  - logo: /static/img/mirxes.png
+    logo2: /static/img/mirxes-2x.png
+    sinceDate: 2018-10-31T04:21:23.894Z
+    nameEN: MiRXES
     type: 医疗健康
-    website: https://www.westlakeomics.com/index/index/index/lang/cn
-    descriptionEN: Founded in July 2020, Westlake Omics (wOmics) is a company
-      focused on using mass spectrometry and other high-throughput molecular
-      quantitative technologies to generate omics data , and applying AI
-      technology to analyze biomedical big data. The company is dedicated to
-      developing advanced mass spectrometry-based proteomics techniques for
-      minute amount of clinical specimens. wOmics's persistent efforts have been
-      propped by its breakthroughs in auxiliary clinical diagnostics and drug
-      discovery empowered by AI and omics big data, facilitating precision
-      medicine.
+    website: https://mirxes.com/
+    descriptionEN: Founded in 2014 as a spin-off from Singapore’s Agency for
+      Science, Technology, and Research (A*STAR) and National University of
+      Singapore (NUS), MiRXES is the world’s leading developer of microRNA
+      centric molecular diagnostic tests, with strong pipelines in Cancer,
+      Cardiovascular and Infectious diseases. MiRXES has physical presence in
+      Singapore, USA, China, and Japan with sales in over 40 countries globally.
+      In 2019, MiRXES launched GASTROClear, the world’s first microRNA blood
+      test for early detection of gastric cancer. In response to the COVID-19
+      pandemic, MiRXES worked with Singapore government agencies to launch
+      Fortitude Kit, Singapore’s first authorized COVID-19 RT-PCR test. Since
+      February 2020, millions of Fortitude tests have been deployed globally.
+  - logo: /static/img/xihuyungulogo.png
+    logo2: /static/img/xihuyungulogo.png
+    sinceDate: 2021-04-14T12:46:59.073Z
+    nameEN: Aldit
+    type: 医疗健康
+    website: https://www.westlakegenetech.com
+    descriptionEN: Aldit is a biotech and biopharma startup, which is committed to
+      leverage AI technology to assist the discovery and development of novel
+      gene editing therapies. AIdit focuses on developing the cutting-edge
+      technologies based on the cooperation between the 3-high (high throughput,
+      high precision, high dimension) biotechnological data production and the
+      deep learning modeling. The AIdit team is highly multi-disciplined and has
+      gathered a group of young experts in the fields including molecular
+      biology, immunology, deep leaning and mathematics.
+  - sinceDate: 2021-01-14T11:00:58.562Z
+    nameEN: "Gritgen "
+    descriptionEN: Founded by the top-notch biologist Dr. Yi Rao in 2019, Gritgen is
+      dedicated to make "Great Science for human health" and committed to
+      becoming a global biotech by innovative research. The company has
+      developed propriatary, next-generation AAV capsid platform and high
+      effient promotor and enhancer system. Combining with the fundamental
+      understanding of the genetics and underlying biology of diseases, Gritgen
+      has developed a robust pipeline spanning from rare diseases to common
+      diseases.
+    website: https://www.gritgen.com/
+    type: 医疗健康
+    logo: /static/img/logo-14.png
+    logo2: /static/img/logo-14.png
+  - sinceDate: 2023-04-13T11:00:58.880Z
+    nameEN: Qi Biodesign
+    descriptionEN: Qi Biodesign was founded in 2021 by leading genome editing
+      scientists Dr. Caixia Gao. Qi Biodesign has established itself as a leader
+      in genomic innovation with its proprietary SEEDIT™ research platform,
+      featuring advanced genome editing tools such as novel RNA-guided
+      nucleases, base editors, plant prime editors, and PrimeRoot™ editors for
+      precise large DNA insertions and manipulations. These technologies enable
+      multiplex gene editing, fine-tuning of gene expression, and
+      high-throughput trait discovery, driving the development of superior
+      biological traits to address global challenges in crop breeding and
+      synthetic biology.
+    website: http://www.qi-biodesign.com/
+    type: 医疗健康
+    logo: /static/img/logo-20.png
+    logo2: /static/img/logo-20.png
 ---